Director Michelle K. Holoubek was mentioned in the article “Pharma Turns to Trade Secrets and Open Source for Software,” published by Managing IP. From the article:

“Pharma companies may struggle to protect software-related trade secrets, however, if they don’t develop these innovations by themselves.

Michelle Holoubek, director at Sterne Kessler in Washington DC, says pharma companies often hire vendors to help them develop code. The trade secrets are more likely to be disclosed if the vendors write the code, simply because more parties are privy to the information, she says.”